Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The absence of published half-life data is a direct consequence of how early this compound is in development: it has been used as a research tool to validate an enzyme target, not as a clinical candidate with a full pharmacokinetic package
NAD+-Sirtuin1-AMPK promotes autophagy
B12 plays a role in energy production by assisting in the metabolism of fats and proteins
Across approximately 900 participants, the adverse event profile was indistinguishable from placebo
US$ 22.56
US$ 27.22
US$ 29.31
US$ 24.46
US$ 24.85
US$ 21.72
US$ 26.13
US$ 23.71
US$ 29.53
